The protective role of host Toll-like receptor-4 in acute graft-versus-host disease

Transplantation

Volumn 90, Issue 10, 2010, Pages 1063-1070

  Imado, Takehito ^a   Iwasaki, Tsuyoshi ^a   Kitano, Sachie ^a   Satake, Atsushi ^a   Kuroiwa, Takanori ^a   Tsunemi, Sachi ^a   Sano, Hajime ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Graft versus host disease; Hepatocyte growth factor; Prostaglandin E 2; Toll like receptor

Indexed keywords

ANTIBIOTIC AGENT; CD68 ANTIGEN; CYCLOOXYGENASE 2; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROSTAGLANDIN E2; SCATTER FACTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; APOPTOSIS; ARTICLE; C3H MOUSE; C57BL 6 MOUSE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; INTESTINE EPITHELIUM; LIVER; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; APOPTOSIS; BASE SEQUENCE; CELL PROLIFERATION; CYCLOOXYGENASE 2; DINOPROSTONE; DNA PRIMERS; FEMALE; GENE EXPRESSION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOCYTE GROWTH FACTOR; IMMUNITY, INNATE; INTESTINES; LIPOPOLYSACCHARIDES; LIVER; MACROPHAGES; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MODELS, IMMUNOLOGICAL; MUTATION; NEUTROPHILS; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78650275424     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181f86947     Document Type: Article

References (33)

1. Hill GR, Crawford JM, Cooke KR, et al. Total body irradiation and acute graft-versus-host disease: The role ofgastrointestinal damage and inflammatory cytokines. Blood 1997;90:3204.
2. Hill GR, Ferrara JL. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: Rationale for the use of cyto-kine shieldsin allogeneic bone marrow transplantation. Blood 2000;95:2754.
3. Fukata MK, Michelsen S, Eri R, et al. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial transloca-tion in a murine model of acute colitis. Am J Physiol 2005;288: G1055.
4. Fukata M, Chen A, Klepper A, et al. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 2006;131:862.
5. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229.
6. Kawai T, Akira S. Pathogen recognition with Toll-like receptors. Curr Opin Immunol 2005;17:338.
7. Cooke KR, Hill GR, Crawford JM, et al. Tumor necrosis factor-alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J Clin Invest 1998;102:1882.
8. Cooke KR, Hill GR, Gerbitz A, et al. Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: Potential role for a gut-lung axis of inflammation. J Immunol 2000;165:6612.
9. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000;68:7010.
10. Toiyama Y, Araki T, Yoshiyama S, et al. The expression patterns of Toll-like receptors in the ileal pouch mucosa of postoperative ulcer-ative colitis patients. Surg Today 2006;36:287.
11. Ortega-Cava CF, Ishihara S, Rumi MA, et al. Epithelial Toll-like receptor 5 is constitutively localized in the mouse cecum and exhibits distinctive down-regulation during experimental colitis. Clin Vaccine Immunol 2006;13:132.
12. Ortega-Cava CF, Ishihara S, Rumi MA, et al. Strategic compartmental-ization of Toll-like receptor 4 in the mouse gut. J Immunol 2003;170:3977.
13. Kuroiwa T, Kakishita E, Hamano T, et al. Hepatocyte growth factor ameliorates acute graft-versus-host-disease and promotes hematopoi-etic function. J Clin Invest 2001;107:1365.
14. Cooke KR, Gerbitz A, Crawford JM, et al. LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J Clin Invest 2001;107:1581.
15. Goodridge HS, Marshall FA, Else KJ, et al. Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62. J Immunol 2005;174:284.
16. Schmassmann A, Stettler C, Poulsom R, et al. Roles of hepatocyte growth factor and its receptor Met during gastric ulcer healing in rats. Gastroenterology 1997;113:1858.
17. Brzozowski T, Nonturek PC, Konturenk SJ, et al. Involvement of cy-clooxygenase (COX)-2 products in acceleration of acute healing by gastrin and hepatocyte growth factor. J. J Physiol Pharmacol 2000;51:751.
18. Gribar SC, Anand RJ, Sodhi CP, et al. The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation. J Leukoc Biol 2008;83:493.
19. Abreu MT, Vora P, Faure E, et al. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 2001;167:1609.
20. Hausmann M, Kiessling S, Mestermann S, et al. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 2002;122:1987.
21. Jones JM, Wilson R, Bealmear PM. Mortality and gross pathology of secondary disease in germ free mouse radiation chimeras. Radiat Res 1971;45:577.
22. van Bekkum DW, Roodenburg J, Heidt PJ, et al. Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst 1974;52:401.
23. Van Bekkum DW, Knaan S. Role of bacterial flora in development of intestinal lesions from graft-versus-host reaction. J Natl Cancer Inst 1977;58:787.
24. Beelen DW, Elmaagacli A, Müller KD, et al. Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: Final results and long-term follow-up of an open-label prospective randomized trial. Blood 1999;93:3267.
25. Oh K, Iimuro Y, Takeuchi M, et al. Ameliorating effect of hepatocyte growth factor on inflammatory bowel disease in a murine model. Am J Physiol Gastrointest Liver Physiol 2005;288: G729.
26. Matsumoto K, Okazaki H, Nakamura T. Novel function of prostaglan-dins as inducers of gene expression of HGF and putative mediators of tissue regeneration. J Biochem 1995;117:458.
27. Morteau O, Morham SG, Sellon R, et al. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygen-ase-2. J Clin Invest 2000;105:469.
28. Pull SL, Doherty JM, Mills JC, et al. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci USA 2005;102:99.
29. Rhee SH, Hwang D. Murine Toll-like receptor 4 confers lipopoly-saccharide responsiveness as determined by activation of NF kappa B expression of the inducible cyclooxygenase. J Biol Chem 2000;275:34035.
30. Sugiyama A, Arakaki R, Ohnishi T, et al. Lipoteichoic acid and inter-leukin 1 stimulate synergistically production of hepatocyte growth factor (scatter factor) in human gingival fibroblasts in culture. Infect Immun 1996;64:1426.
31. Calcaterra C, Sfondrini L, Rossini A, et al. Critical role of TLR9in acute graft-versus-host disease. J Immunol 2008;181:6132.
32. Lorenz E, Schwartz DA, Martin PJ, et al. Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoi-etic stem cell transplantation. Biol Blood Marrow Transplant 2001;7:384.
33. Elmaagacli AH, Koldehoff M, Hindahl H, et al. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation. Transplantation 2006;81:247.